Goldman Sachs Group Inc. (NYSE:GS) Results in Detail

Goldman Sachs’s earnings report beats extimates GS Goldman Sachs Group Inc. (NYSE:GS) rose as much as 6.3% in New York trading after the bank reported profit that exceeded analysts’ estimates, helped by a reduction in compensation costs. The shares gained 6.12 to 103.80 at 12:10 p.m. Q-4 net income at the New York-based Company dropped [...]

Red Alert: AvalonBay Communities, Inc. (NYSE:AVB)

Red’s Bull Trade Alert: AvalonBay Communities, Inc. (NYSE:AVB) 16 November 2011 Profile: AvalonBay Communities, Inc. engages in the development, redevelopment, acquisition, ownership, and operation of multifamily communities in the United States. As of January 31, 2009, the company owned or held a direct or indirect ownership interest in 164 operating apartment communities comprising 45,728 apartment [...]

Red Alert: Lihua International, Inc. (NASDAQ:LIWA)

Red’s Bull Trade Alert: Lihua International, Inc. (NASDAQ:LIWA) 8 November 2011 Profile: Lihua International, Inc., through its subsidiaries, engages in the production of copper replacement cable and wire products in the People’s Republic of China. It develops, designs, manufactures, markets, and distributes refined copper products, including copper anode, pure copper rod, pure copper wire, and [...]

Apple Inc. (NASDAQ:AAPL), are Expanding

Apple expand workforce, R&D in 2011 AAPL Apple Inc. (NASDAQ:AAPL) expanded its work force and increased research and development investments over the past year, according to a financial filing that outlined the tech Giant’s continued growth amid continued interest in its SmartPhone and Tablet products. In its F-Y-end filing with the Securities and Exchange Commission [...]

Red Alert: Acura Pharmaceuticals, Inc. (NASDAQ:ACUR)

Red’s Bull Trade Alert: Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) 19 October 2011 Profile: Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and manufacture of pharmaceutical product candidates utilizing its proprietary Aversion and Impede technologies. Its Aversion Technology is a proprietary platform technology providing abuse deterrent features and benefits to orally administered pharmaceutical [...]

Our members see BIG winners! Sign up now for the hottest stock alerts on the net!
close this